Immunohistochemical Expression of Galectin-8, VEGF-C and VEGFR-3 in Epithelial Ovarian Carcinoma: Associations with Clinicopathological Features

Ovarian carcinoma (OC) is one of the most lethal gynecological malignancies. Galectin-8 (Gal-8) and the VEGF-C/VEGFR-3 lymphangiogenic axis have each been implicated in OC progression, but they have not been examined together in a histotype-resolved series. In this retrospective, cross-sectional, single-center study of 84 epithelial OC cases, Gal-8, VEGF-C and VEGFR-3 immunoexpression was related to histological type, Type I/Type II classification, pT-based stage and residual disease, with correction for multiple testing (q). Gal-8 was nuclear in all 34 high-grade serous carcinomas (HGSCs) and all 42 Type II tumors, whereas cytoplasmic and mixed patterns occurred almost only in low-grade and Type I tumors. A high Gal-8 score was associated with HGSC and Type II histology, poor differentiation, advanced stage and residual disease (odds ratios, all q ≤ 0.004). VEGF-C and VEGFR-3 were expressed in 67.86% and 73.81% of cases, more often in high-grade and advanced tumors, and in all stage III tumors. No statistically significant association was detected between Gal-8 and VEGF-C or VEGFR-3, but the cohort was too small for this comparison to be conclusive. Gal-8, VEGF-C and VEGFR-3 are each associated with aggressive features of OC. This study cannot show whether this reflects a shared aggressive phenotype or a functional interaction between the markers. Without outcome data or multivariable analysis, these findings are descriptive, not prognostic, and hypothesis-generating.

Authors

Institutions

Publication Details

Journal
Current Issues in Molecular Biology
Published
2026-11-18
DOI
https://doi.org/10.3390/cimb48111243
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Immunohistochemical Expression of Galectin-8, VEGF-C and VEGFR-3 in Epithelial Ovarian Carcinoma: Associations with Clinicopathological Features

Andreea Rusu, Irina-Draga Căruntu, Simona Eliza Giuşcă, Ioana Păvăleanu et al.
Current Issues in Molecular Biology
Ovarian cancer diagnosis and treatment
article

Immunohistochemical Expression of Galectin-8, VEGF-C and VEGFR-3 in Epithelial Ovarian Carcinoma: Associations with Clinicopathological Features

Andreea Rusu, Irina-Draga Căruntu, Simona Eliza Giuşcă, Ioana Păvăleanu, Ovidiu Daniel Bîcă, Gabriela Bordeianu, Ludmila Lozneanu, Elena Roxana Avădănei, Andreea Ioana Pruteanu
article en

Abstract

Ovarian carcinoma (OC) is one of the most lethal gynecological malignancies. Galectin-8 (Gal-8) and the VEGF-C/VEGFR-3 lymphangiogenic axis have each been implicated in OC progression, but they have not been examined together in a histotype-resolved series. In this retrospective, cross-sectional, single-center study of 84 epithelial OC cases, Gal-8, VEGF-C and VEGFR-3 immunoexpression was related to histological type, Type I/Type II classification, pT-based stage and residual disease, with correction for multiple testing (q). Gal-8 was nuclear in all 34 high-grade serous carcinomas (HGSCs) and all 42 Type II tumors, whereas cytoplasmic and mixed patterns occurred almost only in low-grade and Type I tumors. A high Gal-8 score was associated with HGSC and Type II histology, poor differentiation, advanced stage and residual disease (odds ratios, all q ≤ 0.004). VEGF-C and VEGFR-3 were expressed in 67.86% and 73.81% of cases, more often in high-grade and advanced tumors, and in all stage III tumors. No statistically significant association was detected between Gal-8 and VEGF-C or VEGFR-3, but the cohort was too small for this comparison to be conclusive. Gal-8, VEGF-C and VEGFR-3 are each associated with aggressive features of OC. This study cannot show whether this reflects a shared aggressive phenotype or a functional interaction between the markers. Without outcome data or multivariable analysis, these findings are descriptive, not prognostic, and hypothesis-generating.

Current Issues in Molecular BiologyVol. 48(11)
Grigore T. Popa University of Medicine and Pharmacy (RO)
Good health and well-being
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon